Solifenacin succinate

Details

Files

Generic Name:

Solifenacin succinate

Project Status:

Complete

Therapeutic Area:

Bladder, overactive

Manufacturer:

Astellas Pharma Canada Inc.

Brand Name:

Vesicare

Project Line:

Reimbursement Review

Project Number:

SR0155-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Resubmission

Indications:

Bladder, overactive

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

June 17, 2009

Files

Recommendation and Reasons View PDF

Last Updated : January 5, 2009